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Abstract
The identification of biosignatures of aerosol exposure to pathogens has the potential to provide useful diagnostic
information. In particular, markers of exposure to different types of respiratory pathogens may yield diverse sets of markers
that can be used to differentiate exposure. We examine a mouse model of aerosol exposure to known Gram negative
bacterial pathogens, Francisella tularensis novicida and Pseudomonas aeruginosa. Mice were subjected to either a pathogen
or control exposure and bronchial alveolar lavage fluid (BALF) was collected at four and twenty four hours post exposure.
Small protein and peptide markers within the BALF were detected by matrix assisted laser desorption/ionization (MALDI)
mass spectrometry (MS) and analyzed using both exploratory and predictive data analysis methods; principle component
analysis and degree of association. The markers detected were successfully used to accurately identify the four hour
exposed samples from the control samples. This report demonstrates the potential for small protein and peptide marker
profiles to identify aerosol exposure in a short post-exposure time frame.
Citation: Wunschel D, Webb-Robertson B-J, Frevert CW, Skerrett S, Beagley N, et al. (2009) Differentiation of Gram-Negative Bacterial Aerosol Exposure Using
Detected Markers in Bronchial-Alveolar Lavage Fluid. PLoS ONE 4(9): e7047. doi:10.1371/journal.pone.0007047
Editor: Neeraj Vij, Johns Hopkins School of Medicine, United States of America
Received February 18, 2009; Accepted August 11, 2009; Published September 16, 2009
Copyright:  2009 Wunschel et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Funding was provided by Pacific Northwest National Laboratory’s Environmental Biomarkers Initiative. Battelle Memorial Institute operates Pacific
Northwest National Laboratory for the U.S. DOE under Contract DE-AC06-76RLO. Support for exposure work was received from the National Institutes of Health
through grant U54 AI057141 awarded to the University of Washington. The funders had no role in study design, data collection and analysis, decision to publish,
or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: David.Wunschel@pnl.gov
¤ Current address: Crop Biometrics Group, Monsanto Corp., Ankeny, Iowa, United States of America
Introduction
Developing molecular markers of infectious disease is a subject
of intense interest. Early detection of infection, prior to the onset of
symptoms and pathology is the ultimate goal. The time scale for
early detection is a few hours to days after infection before
common symptoms of illness (e.g. fever, malaise, and congestion)
appear [1]. This time scale also precedes the mounting of an
effective acquired immune response and is of particular interest for
rapid detection of exposure. Aerosol exposure to infectious agents
is a commonly discussed bioterrorism scenario because of the
potential for affecting large numbers of people [1,2,3,4]. Many of
the diseases, such as anthrax, also require treatment within the first
24 hours, prior to the onset of symptoms, to be most effective [5].
A number of bacterial agents are considered as potentially being
used in bioterror, including Francisella tularensis, the causative agent
of tularemia [6]. In this report, we focus on the tools to examine
the early markers of host response to aerosol exposure in a mouse
model of tularemia.
The early events in the infection and immune response typically
involve interaction by the pathogen with epithelial layers and
resident professional phagocytic cells [7]of the skin, gastrointestinal
or respiratory tracts. The result is often activation of these cell
types to produce antimicrobial compounds and inflammatory
mediators. The protein/peptide markers immediately expressed
and secreted after infection play important roles during the innate
immune response [8,9,10]. A variety of cytokines, chemokines and
defensins have been postulated to serve as important markers of
response for diagnostic purposes [8,10,11]. The technology for
profiling cytokines and chemokine markers has generally em-
ployed affinity reagents because these markers are often present at
picomolar concentrations [12,13]. The challenge of detecting
cytokines becomes larger when examining small or dilute samples,
such as breath condensate [13,14]. A further complication is often
finding the affinity reagents to measure a range of markers,
especially in certain host species [15]. Furthermore, the use of
affinity reagents places limits on marker discovery to only those
proteins with the corresponding antibody reagents used in the
assay.
The pathogenesis of bacterial disease in the lungs can involve
both host and pathogen proteases [16,17,18,19,20]. Host proteases
are required as an activation event for cytokines and defensins
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inactivate or modify important immune effectors such as defensins
and immunoglobulin [18,22,23]. Bacterial proteases are also
directly involved in tissue damage [16,17]. The combination of
expressed immune peptides as well as protease derived degrada-
tion products can potentially generate a number of signature
peptides in response to infection. These peptides may serve as
effective discriminators of host-bacteria interaction and were
targeted for analysis.
Biomarker discovery and profiling by direct matrix assisted laser
desorption/ionization (MALDI) mass spectrometry (MS) or a
more recent variation, surface enhanced laser desorption/
ionization (SELDI) MS has gained wider application for
comparison of clinical samples. Several applications have been
reported including profiling body fluids for detection of cancer and
infectious disease related patterns [24,25]. One area of broad
application for MALDI-MS has been in bacterial identification
[26,27,28,29]. Mass lists of easily extracted and detected markers
from cultured bacterial samples form the basis for comparison and
ultimately, identification of organisms. This requires construction
and searching of large marker databases [30,31]. Two commercial
systems have been designed for this purpose by Bruker Daltonics
and Waters-Micromass [32,33].
Among the strengths of direct MALDI analysis is small sample
size, relative speed of analysis, ease of replication with an inherent
ability to multiplex the analysis. Furthermore, superior mass
resolution and accuracy can be achieved when compared to gel
based separations, as well as an increased sensitivity for low mass
markers [34,35]. However the trade-offs are that MALDI and
SELDI have a much more limited mass range and analyte
suppression is seen for low abundance ions. Different matrices also
provide differential ionization efficiency for individual proteins
and peptides. To address the problem of suppression, subsets of
markers are captured on surfaces or magnetic beads based on
general chemical properties such as hydrophobicity or ion
exchange. Performing the cleanup off the SELDI target allows
flexibility in the amount of material applied and the MS platform
used for analysis.
Building on this approach we investigate combination of an acid
extraction and two stage solid phase sample extraction coupled to
a MALDI-MS analysis to profile markers of response to infection
in the lung. The targeted capture of biomarkers used in this study
is based on known characteristics of antimicrobial peptides,
principally their acid solubility and cationic nature. In this report,
we investigate the use of an acid extraction in conjunction with a
two step solid phase extraction (SPE) using strong cation exchange
and reverse phase to profile markers using MALDI-MS. This
approach is applied to investigating patterns of markers produced
in response to pathogens.
A mouse model of aerosol exposure and infection for three
organisms was examined using this technique. Two pathogens
Francisella tularensis ssp novicida (F. novicida), and Pseudomonas
aeruginosa were used along with a non-pathogenic mutant of F.
novicida that lacks the transcriptional regulator mglA. F. novicida
infection in mice serves as a model for human infection with the
category A pathogen, F.tularensis ssp tularensis [36]. F. novicida is
highly virulent in mice with any exposure, while very rarely
pathogenic in man [37].
The major endotoxin component of the gram negative cell, the
lipid A portion of the lipopolysaccharide (LPS), elicits a poor host
cytokine response for Francisella pathogens [36,38]. This is thought
to limit the innate immune response to this intracellular pathogen.
Portions of the pilis IV regulatory apparatus were also found to be
essential for pathogenesis of this organism [39]. The deletion of the
transcriptional regulator for this apparatus creates a non-
pathogenic mutant in mice and is of interest in studying the host
response. While other pathogenesis factors are likely to exist, these
factors aid in the evasion of the immune response to Francisella.
The goal of this study was to determine if distinct profile of
exposure markers could be detected using the capture and
purification of peptide markers prior to MALDI-MS analysis.
The study was conducted using an experimental design to limit
effects of exposure time or order prior to sample collection. Four
mice were studied for each treatment and time group with
replication and randomization of the MALDI-MS data collection.
Following data collection, tools for spectral alignment and peak
picking were used for data reduction. The experimental design
provided an effective tool to allow discovery of significant markers
using a non-parametric analysis of variance.
Results
Bronchial Alveolar Lavage (BAL) Fluid Cell Measurements
The bacterial cell load was assessed through direct culture in
separate experiments. As seen in table 1, the number of colony
forming units was measured to be one to four thousand for both
the wild-type (Fn) and attenuated (Fn-ATT) F. novicida with
significantly larger dose measured for the P. aeruginosa (Pa)
exposure.
The response to bacterial exposure was measured by the
number of immune cells found in the BAL fluid for four mice in
each group. Both mononuclear (MN) and poly morphonuclear
(PMN) cells were counted in the BAL at 4 h, 24 h, and 48 h for Fn
and Fn-att and at 4 h and 24 h for Pa. (Figure 1). The total cell
counts revealed differences between each type of exposure. At
4 hours, only the Pa exposure showed a significant increase in cell
count while at 24 hours both Pa and Fn showed a significant
increase in immune cell recruitment. Much of this data can be
explained by differences in PMN count alone (Figure 1B). No
PMN are seen in the 0 hour control and only the Pa sample
contained PMN at 4 hrs. The Pa and Fn samples showed PMN at
24 hrs similar to the total cell count data.
MALDI-MS Mass Measurement
Mass spectral comparisons rely on reproducible measurements
and assessment of the variability of those measurements. Mass
calibration for the plate was done using plate locations to calibrate
an area of the plate with each sample being within three plate
locations of the calibrant. Sinapinic acid was also chosen as the
MALDI matrix because of the increased instrument performance
with greater peak resolution over another common matrix, a-
hydroxy cinnamic acid (data not shown). Typical peak resolutions
were estimated using external calibrant peaks appearing in the
same m/z range as many of the markers observed, such as
ubiquitin ([M+H]
+ theo. m/z 8565.89) and cytochrome c ([M+2H]
Table 1. Measurement of bacterial deposition in colony
forming units (CFU) per lung for virulent (Fn) and attenuated
(Fn-ATT) F. novicida and P. pseudomonas (Pa) with standard
error of the mean (SEM) indicated for each measurement.
Fn-1 Fn-2 Fn-ATT-1 Fn-ATT-2 Pa
CFU/lung 4248 3030 3827 1262 126127
SEM 1215 214 815 408 14239
doi:10.1371/journal.pone.0007047.t001
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well as an average mass measurement accuracy of 25 ppm and
precision of 130 ppm. The peak statistics for sample markers
indicated slightly lower performance for a commonly observed
marker in BALF, m/z 3349.4. The standard deviation of the mass
measurement was 0.92 m/z (precision of 274 ppm) was deter-
mined over fifteen replicate mass measurements with an average
peak resolution of 390 +/2 30.
To increase consistency of data acquisition, ground stainless
steel sample plates were used to provide more reproducible crystal
formation with the chosen matrix. However, despite the mass
resolution advantages, sinapinic acid tends to form less homoge-
neous crystals than a-hydroxy cinnamic acid. Therefore it was
determined that 500 laser shots needed to be acquired in 50 shot
intervals to get a representative mass spectrum for each spot.
Feature Extraction
Following acquisition, the data were analyzed based on the set
of 219 binary peaks. Peaks were picked using an approach
previously applied to MALDI-MS spectra of bacterial samples
[40]. For this analysis, all control time points were combined as a
single group totaling 12 mice. Of the 219 peaks, only ,5% were
deemed significant by Kruskal-Wallis with a Bonferroni correction
for multiply hypothesis tests, Table 2. Examples of MALDI-MS
data used in the study are provided in Fig. 2 showing comparison
of Fn-4 hr sample to a Pa-4 hrs sample. Several of the masses
determined to be significant in table 2 are present in the Pa-4 hr,
including m/z 5555.1, 1674.5 and 1792.8.
Discriminatory Power of Biosignatures
As seen in Figure 3, some separation can be viewed for the
different treatment classes from a standard Principal Component
analysis (PCA). Missing data were imputed using a simple
probability based method. If a peak was observed over 50% of
the time the value was imputed as the average intensity, otherwise
it was imputed as K of the minimum observed intensity. However,
only ,17.4% of the variability is explained in these first two
components. Clearly the various treatments were distinct from the
control samples of all time points. The Fn ATT samples also
seemed to produce the most distinct response using these two
principle components. The PCA gives some indication of
distinctness of groups, however since imputation is not standard
for MALDI, in-complete data methods, such as fingerprinting, are
a more appropriate analytical method for MALDI.
Since our sample size was relatively small, most of the seven
groups of interest, have only four samples, leave-one-out cross-
validation (LOOCV) was used to classify each sample in a manner
that was independent from the data used to build the reference
fingerprints. Degree of association was used to build a predictive
model on 35 of the 36 samples and a fingerprint was generated for
the left out sample and probabilistically assigned to a class (Eq. 2).
Table 3 summarizes the results with respect to each class in which
27 of the 36 samples are appropriately classified.
The statistical approach to classifying marker sets demonstrated
an ability to discriminate classes of exposure 75% of the time. Not
all treatment groups could be equally well defined using this
approach. In the case of Pa-4 was accurately predicted for all four
animals and Pa-24 three of the four times. The Fn-ATT-4, Fn-
ATT-24 and Fn-4 were also predicted with relatively high
confidence with all four mice for Fn-ATT-4 and three of four
mice for the other two classes. The class that was most difficult to
predict was Fn-24, where only one in four mice was correctly
predicted and the other three mice predicted to be in three
different treatment classes.
Discussion
The goal of this study was to determine if the host response to
aerosol exposure by different organisms would differ in the profile
of peptides and small proteins captured in BALF. Three distinct
types of organism challenges were used and compared to control
animals. The samples were collected at two relatively short time
points following exposure in an attempt to capture marker profile
changes early in the host response. A number of different steps in
the experimental process including aerosol exposure, sample
purification and instrumental analysis could introduce bias in the
data. Therefore, it was important to utilize effective experimental
design for both exposure and analysis to limit the effects of the
experimental process on data interpretation.
The differences in markers detected between the Fn and Pa
exposures may have several possible explanations. Differences in
reactivity between the major inflammatory component of the
outer membrane, the LPS, between F. novicida and other gram
negative organisms would indicate different host responses should
be anticipated. The resulting pathology that is observed after P.
aeruginosa and F. novicida infection is also distinct where the former
Figure 1. Total number of mononuclear (MN) and poly
morphonuclear (PMN) cells counted in the BAL fluid at 4 h,
24 h, and 48 h for Fn and Fn-ATT and at 4 h and 24 h for Pa
(A). Error bars indicate the standard error of the mean (SEM) for each.
Percent PMN cells in BAL fluid (B).
doi:10.1371/journal.pone.0007047.g001
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lung necrosis.
The differences between pathogens could also be seen using the
total cell count. At four hours, only the Pa exposed animals
appeared significantly different. However by 24 hours, the Pa and
Fn treatments are distinct from the control and Fn-ATT treated
animals. Finally, only the Fn treated animals had significant
immune cell counts by 48 hours. While the cell count data
differentiates each type of infection, this type of data may be
difficult to acquire routinely in a clinical setting.
The use of MALDI-MS as a tool to profile and compare
markers has several advantages. The ability to examine a large
number of samples in a relatively small period of time with
extensive analytical replication provides a distinct advantage over
other methods for protein and peptide analysis. The tools for
comparison of spectra data have been developed for several
applications. However our approach to data analysis was
developed through experience with bacterial identification and
utilizes a different approach to spectral analysis than commercially
available software packages. Our approach relies solely on peak
presence/absence rather than peak intensity or area. This is
intended to limit the affect of peak area variability that has been
previously described [40,41].
The results of this study indicate that the small protein and
peptide markers analyzed by this method could be used as
surrogates to indicate the type of exposure the mouse had
Figure 2. Example mass spectra comparing of a portion of the mass range for a Fn-4 hrs sample (A) and a Pa-4 hrs sample (B).
doi:10.1371/journal.pone.0007047.g002
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pathogenic control were used in this study. For the earliest time
point, four hours, the marker sets could be distinguished for all but
one animal between each other and the control animals. While the
markers are identified solely based on the measured mass, this
study illustrates their potential utility. A second issue is that the
biological origin of the markers is thought to be from the host,
however that has not been determined experimentally. Isolation
and identification of these markers will help elucidate their
biological origin and significance.
One consideration is the change in marker sets between
different time points, and presumably stages, of a given type of
exposure and infection. In the case of F. novicida, the endpoint for
all exposures is lethal. The change in marker sets from the initial
exposure to a largely intracellular survival strategy may explain a
corresponding shift in the marker sets observed in this study. A
time-dependent shift in expression has been observed in previous
work for some cytokines and chemokines following F. novicida
exposure [37]. While those time-dependent changes were
monitored over longer time intervals (24 to 48 hours), it may be
Table 2. The significant peaks with a p-value of less than 0.05
based on a Kruskal-Wallis test of the data.
Peak Number m/z p-value (Kruskal-Wallis)
41 1674.51 0.009
50 1792.82 0.009
101 2786.32 0.014
119 3155.06 0.014
174 5067.34 0.014
187 5555.09 0.014
197 6119.09 0.045
126 3418.68 0.037
14 1100.56 0.040
71 2208.52 0.049
231 8408.89 0.049
doi:10.1371/journal.pone.0007047.t002
Figure 3. Distribution of replicate samples for seven classes of treatment: Control, PA-4 hrs, PA-24 hrs, Fn-4 hrs, Fn-24 hrs, Fn ATT-
4 hrs, Fn ATT-24 hrs using two principle components.
doi:10.1371/journal.pone.0007047.g003
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such as those examined in this study.
Lastly, it is unknown if these markers are present in more
accessible biological samples, such as breath condensate. However,
previous studies examining different types of markers, such as lipid
mediators, have demonstrated their presence in breath condensate
[3]. A goal is to utilize these more accessible sample types in order
to be useful for diagnosis of respiratory infection.
Materials and Methods
Materials
The acetic acid, triflouroacetic acid, acetonitrile, methanol,
PMSF and ammonium hydroxide, ammonium acetate, ammoni-
um bicarbonate was obtained from Sigma (St Louis, MO) at the
highest purity available. The phosphate buffered saline (PBS) was
obtained from Cell Gro (Voigt global inc, Lawrence, KS).
Microcon molecular weight cutoff (MWCO) filters were purchased
from Millipore (Burlington, MA). The 1 ml (100 mg bed volume)
reverse phase C-18 T (P/N 8B-S004-EAK) and the 1 ml (30 mg
bed volume P/N 8B-S029-TAK) strata X-C strong cation
exchange solid phase extraction (SPE) cartridges were obtained
from Phenomenex (Torrance, CA). The hydrophobic interaction
(C-18) magnetic beads (MB-HIC) as well as protein and peptide
mass calibration standards (P/N 219042) were purchased from
Bruker Daltonics (Billerica MA).
Bacterial Cultures
Francisella novicida U112 (Fn) and the F. novicida mglA mutant (Fn
ATT) were provided by Dr. Francis Nano (University of Victoria,
Canada). Pseudomonas aeruginosa PAK (Pa) was obtained from Dr.
Steve Lory (Harvard University). Glycerol stocks were inoculated
1:1000 into nutrient broth (TSB-0.1% L-cysteine for F. novicida
strains and LB for P. aeruginosa) and incubated for 16 h at 37uCi na
rotating platform incubator at 200 rpm. Bacteria were pelleted by
centrifugation at 4uC, washed twice with PBS and resuspended in
5 ml cold PBS. Bacterial concentrations were estimated by optical
density, using an OD450 of 0.2 as indicating a concentration of
2610e9 CFU/ml (Fn and Fn ATT) or 2610e8 CFU/ml (Pa). All
bacteria were mixed thoroughly and diluted to 5610
‘9 CFU/ml
in PBS in a total of 11 ml, of which 10 ml were used for each
aerosolization.
Aerosol exposure of mice
All animal experiments were approved by the Institutional
Animal Care and Use Committee of the University of Washington
(Seattle, Washington). Specific pathogen-free male and female
C57BL/6 mice were obtained from Jackson Labs (Bar Harbor,
ME) and were 8 weeks of age at the time of study. Mice were
housed in filtered cages in a laminar flow rack (BioZone (Fort Mill,
SC), and were permitted ad lib access to sterile food and water.
For inhalation challenges, mice were placed in individual
restraining tubes and exposed to aerosolized bacteria or PBS
using a snout-only inhalation system (In-Tox Products, Moriarty,
NM). Aerosols were generated using Mini-Heart Hi-flo nebulizers
(Westmed, Tucson, AZ) driven at 44 psi with flow maintained at
2.5–2.6 L/min. Total airflow through the chamber was main-
tained at 17–26 L/min by negative pressure. Aerosol exposures
were conducted for ten min, followed by 5 min purging with air.
After each exposure the chamber was sterilized with Process NPD.
Aerosol exposure experiments were conducted over 2 days using
the following schedule:
Day 1:
1. PBS (8 mice)
2. Sterilization and clean
3. F. novicida (Fn - 6 mice)
4. Sterilization and clean
5. F. novicida mglA mutant (Fn-ATT - 6 mice)
6. Sterilization and clean
Day 2:
1. P. auriginosa (PAK) (Pa- 8 mice)
2. Sterilization and clean
3. F. novicida (Fn - 6 mice)
4. Sterilization and clean
5. F. novicida mglA mutant (Fn-ATT - 6 mice)
6. Sterilization and clean
7. PBS (8 mice)
Actual deposition of bacteria in the lungs was determined by
quantitative cultures of lung tissues harvested from three sentinel
mice immediately after each aerosol exposure, as described
[42,43]. The measured number of bacteria deposited lung with
this treatment is provided in table 1.
Collection of bronchial alveolar lavage fluid
Mice samples were harvested at T=0 (PBS exposed only), 4H,
24H, and 48H (for PBS only); at 4H and 24H for F. novicida, F.
novicida mglA mutant and P. auriginosa PAK post exposure. The
samples were collected after the mice were anesthetized with
pentobarbital and exsanguinated by heart puncture. The trachea
Table 3. The class predictions of the full 7 class Degree of Association model (Global Accuracy ,75.0%).
Predicted Class
C Pa-4 Pa-24 Fn-4 Fn-24 Fn-ATT-4 Fn-ATT-24
True C 0.75 0.17 0.08
Class Pa-4 1.00
Pa-24 0.75 0.25
Fn-4 0.25 0.75
Fn-24 0.25 0.25 0.25 0.25
Fn-ATT-4 1.00
Fn-ATT-24 0.25 0.75
doi:10.1371/journal.pone.0007047.t003
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Both lungs were lavaged by instilling 0.8 ml64 of warm lavage
fluid (0.9% saline with 0.6 mM EDTA). The lavage fluid was spun
at 1200 rpm at room temperature and aliquoted with a final
concentration of 1 mM PMSF.
Culture supernatant preparation and acid extraction
A 0.2 mL portion of the bronchial alveolar lavage fluid (BALF)
was applied to a Microcon 30 MWCO micro centrifuge spin
filters. After centrifuging at 10,000 RCF for 30 minutes, the filtrate
was collected. Acetic acid was added to a final concentration of 2%
and the samples were allowed to incubate for 5 minutes at room
temperature. The samples were then centrifuged again at
10,0006g for five minutes to remove any precipitated material.
The supernatants were applied to C-18 SPE cartridges placed on
a vacuum apparatus that were previously conditioned according to
the manufacturer recommendations. After washing with two 1 ml
volumes of 0.1% TFA, the samples were eluted using 1 mL of 90%
acetonitrile and 0.1% TFA into 1.5 mL eppendorf tubes. The
eluted material was dried under nitrogen gas. Each sample was
resuspended in 25 mL of 10% acetonitrile 0.1% TFA.
Two stage SPE sample fractionation and cleanup
The mouse BALF samples were prepared for mass spectrometry
in twelve sample batches using a twelve port manifold. As a result,
a randomization order for preparation and analysis was employed.
Table 2 contains the sample order used.
Two stages of SPE were employed in purification of the peptide
fraction following a 30 kDa molecular weight cutoff purification
step and acetic acid extraction. The strata-X-C column was
conditioned with 2 mL of MeOH, 2 mL of 10 mM ammonium
acetate (in 25% acetonitrile, 0.1% TFA pH 3.0), 2 mL of 500 mM
ammonium acetate (in 25% acetonitrile, pH 6.8), 2 mL HPLC
grade water, 2 mL 10 mM ammonium acetate (in 25% acetoni-
trile, 0.1% TFA pH 3.0) followed by vacuum to dry.
The 0.15 ml of acidified, filtered supernatant was added along
with 0.85 mL of 10 mM ammonium acetate (in 25% acetonitrile,
0.1% TFA pH 3.0).After drawing the sample through the SPE
bed, it was washed with 1 ml of 10 mM ammonium acetate (in
25% acetonitrile, 0.1% TFA pH 3.0), 1 ml of 100 mM ammoni-
um acetate (in 25% acetonitrile, 0.1% TFA pH 3.0). Finally the
sample was eluted with 1 mL of 80% MeOH/5% NH4OH. The
eluate was dried under N2 to a volume of ,50–100 mL and then
brought up to a volume of 1 ml with 0.1% TFA.
Finally a C-18 hydrophobic interaction resin was used to clean-
up marker for mass spectral analysis. The C-18 SPE was first
conditioned using 2 mL of MeOH, 2 mL of H2O and 1 ml of
0.1% TFA. The reconstituted sample was then loaded and washed
with 2 mL of 0.1% TFA. The peptides were then eluted into a
clean 1.5 ml eppendorf tube with 1 ml of 90% Acn/0.1% TFA.
The sample was dried under N2 flow and resuspended in 20 mLo f
10% Acn/0.1% TFA or keep dry for longer term storage.
Matrix assisted laser desorption/ionization mass
spectrometry
The mass spectrometric analysis of purified proteins was
performed using an Autoflex II MALDI tandem time of flight
mass spectrometer equipped with a HIMAS
tm detector (Bruker
Daltonics, Billerica MA). Protein samples were spotted on a
ground steel 384 multi target plate using 0.5 mL of sample followed
immediately by 0.5 mL of matrix solution. Sinapinic acid (SA)
matrix was used as a 10 mg/ml solution in 70% acetonitrile/
0.03% TFA.
Five sample spots were deposited for each sample with
successive samples in a statistically randomized order and
deposited in a horizontal pattern. Five replicate spots for each
sample type deposited in a vertical column. An external mass
calibration was performed using protein standard mix II: Bovine
myoglobin, cytochrome c, ubiquitin and insulin; spotted on
adjacent locations.
Data was collected in linear mode from 1,000 to 30,000 m/z
using a pulsed ion extraction delay time of 120 nsec. The resulting
mass spectra consisted of 500 laser shots summed together.
Automated data collection proceeded across each horizontal row
before proceeding to the subsequent row containing the next set of
replicate sample spots. This aided in randomizing data collection.
Data was processed using available functions in the vendor
software including a baseline subtraction and smoothing function
(Savitzky-Golay with 0.2 m/z window) followed by peak picking
using the centroid function and retained peaks with s/n greater
than 5.
Mass spectral data comparison
Mass spectra were compared using Clinprotools 2.0 (Bruker
Daltonics, Billerica MA) for initial quality control of data. The goal
of this analysis was to assess spectral quality and identification of
missing data. Realignment and recalibration was done using the
following settings within the software. Spectral preparation utilized
the Convex Hull baseline function over a 1000–50,000 m/z range.
Peak picking utilized a noise reduction threshold ignoring peaks
below s/n two and picking peaks with s/n greater than five. The
recalibration used a minimum resolution of 100 with a 0.2%
maximum peak shift requiring 30% match to the calibrant peaks.
Feature Extraction
Peaks are detected using an automated peak detection algorithm
developed at PNNL [41] creating a list of peak locations (m/z) and
associated intensity values from the mass spectrum of each sample.
Targeting peptides, we consider only peaks having an m/z of less
than 10,000. Following methods described in [41], the full set of
spectra (all technical replicates from all experimental replicates)
are aligned by combining the extracted peak lists and calculating
an aligned peak location for each peak by averaging the m/z
values from the samples in which that peak exists. This creates a
peak table with each row representing a sample, each column an
aligned peak, and each entry being either the intensity of a peak
occurring in a sample or a missing peak flag if that peak doesn’t
occur in that sample. The code for the peak detection and
alignment algorithms runs in MatLabH Version R2008a.
A Kruskal-Wallis test [44] was used to extract the relevant peaks
from the full peak file using the MatLabH Version R2008a. The
Kruskal-Wallis test is a nonparametric version of one-way analysis
of variance, which tests the hypothesis that samples are drawn
from the same population. The test will return a significant p-value
if anyone of the defined groups has a normalized average peak
area over the replicates that are significantly different from any of
the rest. The Kruskal-Wallis test was based on seven groups in the
data: (1) Control, (2) Pa (4 Hrs), (3) Pa (24 Hrs), (4) Fn (4 Hrs), (5)
Fn (24 Hrs), (6) Fn-ATT (4 Hrs), and (7) Fn-ATT (24 Hrs). The
results of the Kruskal-Wallis test are summarized in Table 2.
Classification – Degree of Association
MALDI spectra were used to separate out the defined treatment
and time groups. A mass spectral fingerprinting algorithm based
on the degree of association between a MALDI reference library
and the spectra of interest was used [40]. In particular the null
hypothesis (HO) that a specific sample is from class k (e.g. Fn at
Markers of Host Response
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sample is not from class k. Assuming HO the sample under
consideration can be described by the probability of observing
peak i (pi). These probabilities are compared to the reference
fingerprint of class k based on the set of fingerprint peaks that are
differ and are in common between the sample fingerprint and the
reference fingerprint – Degree of Association (DA):
da k ðÞ ~1{ P
i[MC pi P
i[M
1{pi ðÞ

, ð1Þ
M is the fingerprint peaks that are not observed in the sample, i.e.
missing, and M
C is the complement, or observed peaks. All
fingerprints are also subject to an occurrence filter that requires
that a peak be observed in at least 60% of the replicates to be
included in the fingerprint. The code to compute the DA for a
fingerprint runs in MatLabH Version R2008a. The result of the
model is the likelihood that that the sample is in the modeled class.
Thus, the final classification of a sample i (si) is taken to be the class
k (ck) that the sample is classified in with maximum discrimination:
max
k~1   7
DA(sijck ðÞ : ð2Þ
Model Validation
A key step when fitting models that are to be used for prediction
is to verify the results using cross-validation (CV). CV essentially is
an approach to se gregate the data into independent sets so that
the observations that are used to estimate the parameters of the
model are not used to evaluate the classification accuracy [45]. In
particular, with the DA fingerprint model leave-one-out CV
(LOOCV) is used to evaluate the model accuracy. In LOOCV a
single observation is left out of the model training phase. The
trained DA fingerprint model is then run on this left out
observation and the results are evaluated for classification
accuracy. Iterating this process for each observation in the dataset
returns a result for each observation that was attained in a manner
that is independent from the data used to fit the model.
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